LUMOS PHARMA INC shareholders Q2 2023

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 37 filers reported holding LUMOS PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

LUMOS PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Acuitas Investments, LLC 153,867$507,7610.30%
Lion Point Capital, LP 78,351$258,5580.12%
Minerva Advisors LLC 26,549$840.06%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 31,088$102,5910.02%
Greenwich Wealth Management LLC 49,002$1620.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
Leucadia National 120,651$398,1480.00%
West Financial Advisors, LLC 784$2,5880.00%
Renaissance Technologies 231,159$7630.00%
OSAIC HOLDINGS, INC. 4,906$16,1870.00%
DIMENSIONAL FUND ADVISORS LP 20,089$66,3280.00%
BANK OF AMERICA CORP /DE/ 1,800$5,9400.00%
WELLS FARGO & COMPANY/MN 321,889$1,062,2330.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 150$4950.00%
GEODE CAPITAL MANAGEMENT, LLC 54,279$179,1200.00%
External links

This page lists LUMOS PHARMA INC's shareholders in Q2 2023. To view LUMOS PHARMA INC's shareholder history, click here.